Insider Buying: LifeMD, Inc. (NASDAQ:LFMD) Insider Acquires $21,700.00 in Stock

LifeMD, Inc. (NASDAQ:LFMDGet Rating) insider Stefan Galluppi bought 10,000 shares of LifeMD stock in a transaction dated Tuesday, May 23rd. The shares were acquired at an average cost of $2.17 per share, for a total transaction of $21,700.00. Following the completion of the purchase, the insider now directly owns 17,841 shares of the company’s stock, valued at approximately $38,714.97. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

LifeMD Stock Performance

LifeMD stock opened at $2.17 on Friday. LifeMD, Inc. has a fifty-two week low of $1.14 and a fifty-two week high of $3.22. The stock has a market cap of $70.33 million, a price-to-earnings ratio of -1.72 and a beta of 1.30. The stock’s 50 day simple moving average is $1.66 and its two-hundred day simple moving average is $1.91.

LifeMD (NASDAQ:LFMDGet Rating) last posted its quarterly earnings data on Wednesday, March 22nd. The company reported ($0.40) earnings per share (EPS) for the quarter. LifeMD had a negative return on equity of 7,255.81% and a negative net margin of 29.44%. The firm had revenue of $28.12 million during the quarter.

Institutional Investors Weigh In On LifeMD

Several hedge funds have recently bought and sold shares of LFMD. Jane Street Group LLC purchased a new position in shares of LifeMD during the second quarter valued at approximately $25,000. Squarepoint Ops LLC bought a new position in LifeMD during the 1st quarter valued at approximately $28,000. Renaissance Technologies LLC raised its stake in LifeMD by 50.0% during the first quarter. Renaissance Technologies LLC now owns 16,500 shares of the company’s stock valued at $28,000 after buying an additional 5,500 shares during the last quarter. CI Private Wealth LLC bought a new stake in LifeMD in the fourth quarter worth $29,000. Finally, Virtu Financial LLC purchased a new stake in shares of LifeMD in the fourth quarter worth $62,000. Institutional investors own 17.01% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, BTIG Research decreased their price objective on shares of LifeMD from $8.00 to $7.00 and set a “buy” rating for the company in a report on Thursday, March 23rd.

About LifeMD

(Get Rating)

LifeMD, Inc is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The firm combines virtual medical treatment with prescription medications and over-the-counter products. It operates through the Telehealth and WorkSimpli segments. The company was founded in 1987 and is headquartered in New York, NY.

Featured Stories

Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with's FREE daily email newsletter.